Bill Texts: NY S08040 | 2023-2024 | General Assembly

Bill Title: Requires health insurance policies and medicaid to cover biomarker precision medical testing for diagnosis, treatment, or appropriate management of, or ongoing monitoring to guide treatment decisions for, a covered person's disease or condition when the test has recognized efficacy and appropriateness for such purposes.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2024-01-29 - SUBSTITUTED BY A8502 [S08040 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2024-01-05HTML/TextLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for New York S08040

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for New York S08040 currently on file.

Social Comments on NY S08040

feedback